https://www.indianpharmapost.com/cipla-eu-to-invest-15-million-in-ethris-135182022-12-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/claim-against-dr-reddys-laboratories-dismissed-over-revlimid-in-us-135192022-12-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/samples-taken-from-marion-biotech-noida-facility-sent-to-rdtl-chandigarh-for-testing-135202022-12-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/eye-q-inaugurates-its-new-facility-in-yamunanagar-135212022-12-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-announces-positive-topline-results-from-phase-3-study-of-hemophilia-b-gene-therapy-candidate-135222022-12-30T00:00:00+05:30always0.9